US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...
RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...
Celestica Inc . (NYSE:CLS) stock has reached an unprecedented milestone, soaring to an all-time high of $131.34. This ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $162.95, a high estimate of ...
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.
In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...
Triton International Limited (the "Company" or "Triton") today announced the pricing of an underwritten offering of 6,000,000 of the Company’s 7.625% Series F Cumulative Redeemable Perpetual ...